143 related articles for article (PubMed ID: 8721386)
21. Administration of a receptor antagonist for platelet-activating factor during equine endotoxaemia.
Carrick JB; Morris DD; Moore JN
Equine Vet J; 1993 Mar; 25(2):152-7. PubMed ID: 8385601
[TBL] [Abstract][Full Text] [Related]
22. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
Bastos da Silva M; Delaunois A; Gustin P; Godeau JM; Lekeux P
Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205
[TBL] [Abstract][Full Text] [Related]
23. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.
László F; Whittle BJ; Moncada S
Br J Pharmacol; 1994 Dec; 113(4):1131-6. PubMed ID: 7889265
[TBL] [Abstract][Full Text] [Related]
24. Effects of ONO-6240, a platelet-activating factor antagonist, on endotoxin shock in unanesthetized sheep.
Toyofuku T; Kubo K; Kobayashi T; Kusama S
Prostaglandins; 1986 Feb; 31(2):271-81. PubMed ID: 3754344
[TBL] [Abstract][Full Text] [Related]
25. Sequential release of tumour necrosis factor, platelet activating factor and eicosanoids during endotoxin shock in anaesthetized pigs: protective effects of indomethacin.
Mózes T; Zijlstra FJ; Heiligers JP; Tak CJ; Ben-Efraim S; Bonta IL; Saxena PR
Br J Pharmacol; 1991 Nov; 104(3):691-9. PubMed ID: 1797328
[TBL] [Abstract][Full Text] [Related]
26. BB-882 is a potent antagonist of the haemodynamic changes induced by platelet-activating factor in pigs.
Abu-Zidan FM; Walther S; Lennquist S
Pharmacol Toxicol; 1996 Jan; 78(1):23-7. PubMed ID: 8685082
[TBL] [Abstract][Full Text] [Related]
27. Platelet-activating factor receptor antagonist attenuates endotoxin-induced vascular hyporeactivity in the pithed rat.
Yoshikawa D; Shiga T; Saito S; Morita T; Imai T; Goto F
Eur J Pharmacol; 1998 Jan; 342(2-3):241-5. PubMed ID: 9548392
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary and neutrophil responses to priming effects of platelet-activating factor in pigs.
Kruse-Elliott KT
Am J Vet Res; 1997 Dec; 58(12):1386-91. PubMed ID: 9401686
[TBL] [Abstract][Full Text] [Related]
29. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S
Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
[TBL] [Abstract][Full Text] [Related]
30. Effect of TCV-309, a novel platelet activating factor antagonist, on hemodynamics in dogs with endotoxin-induced shock.
Okano S; Tagawa M; Urakawa N
J Vet Med Sci; 1995 Apr; 57(2):385-7. PubMed ID: 7492672
[TBL] [Abstract][Full Text] [Related]
31. Effect of platelet activating factor antagonist (TCV-309) on lung injury in dogs with experimentally endotoxin-induced shock.
Okano S; Tagawa M; Urakawa N
J Vet Med Sci; 1995 Aug; 57(4):751-3. PubMed ID: 8519912
[TBL] [Abstract][Full Text] [Related]
32. Ex vivo effects of SR 27417, a novel PAF antagonist, on rabbit platelet aggregation and [3H]-PAF binding.
Herbert JM; Laplace MC; Maffrand JP
J Lipid Mediat; 1992 Feb; 5(1):1-12. PubMed ID: 1327264
[TBL] [Abstract][Full Text] [Related]
33. Cardiac functional and structural alterations induced by endotoxin in rats: importance of platelet-activating factor.
Iwase M; Yokota M; Kitaichi K; Wang L; Takagi K; Nagasaka T; Izawa H; Hasegawa T
Crit Care Med; 2001 Mar; 29(3):609-17. PubMed ID: 11373429
[TBL] [Abstract][Full Text] [Related]
34. Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock.
Weitzberg E; Hemsén A; Rudehill A; Modin A; Wanecek M; Lundberg JM
Br J Pharmacol; 1996 Jun; 118(3):617-26. PubMed ID: 8762086
[TBL] [Abstract][Full Text] [Related]
35. The role of platelet-activating factor in lipopolysaccharide-induced myocardial depression in guinea pigs.
Heard SO; Toth I; Perkins M
J Crit Care; 1995 Mar; 10(1):7-14. PubMed ID: 7757142
[TBL] [Abstract][Full Text] [Related]
36. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.
Quinn JV; Slotman GJ
Crit Care Med; 1999 Nov; 27(11):2485-94. PubMed ID: 10579269
[TBL] [Abstract][Full Text] [Related]
37. Effect of platelet-activating factor receptor antagonism on endotoxin-induced lung dysfunction in awake sheep.
Christman BW; Lefferts PL; Blair IA; Snapper JR
Am Rev Respir Dis; 1990 Dec; 142(6 Pt 1):1272-8. PubMed ID: 2174655
[TBL] [Abstract][Full Text] [Related]
38. An antagonist of platelet-activating factor suppresses endotoxin-induced tumor necrosis factor and mortality in mice pretreated with carrageenan.
Ogata M; Matsumoto T; Koga K; Takenaka I; Kamochi M; Sata T; Yoshida S; Shigematsu A
Infect Immun; 1993 Feb; 61(2):699-704. PubMed ID: 8423096
[TBL] [Abstract][Full Text] [Related]
39. Similar coronary vascular effects in the rat perfused heart of platelet-activating factor structural analogues with agonist and antagonist properties.
Man RY; Kinnaird AA
Br J Pharmacol; 1995 Nov; 116(5):2359-64. PubMed ID: 8581269
[TBL] [Abstract][Full Text] [Related]
40. Role of platelet activating factor in development of thrombocytopenia and neutropenia in dogs with endotoxemia.
Tsuchiya R; Kyotani K; Scott MA; Nishizono K; Ashida Y; Mochizuki T; Kitao S; Yamada T; Kobayashi K
Am J Vet Res; 1999 Feb; 60(2):216-21. PubMed ID: 10048555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
